Cargando…

Predictive Factors of Piperacillin Exposure and the Impact on Target Attainment after Continuous Infusion Administration to Critically Ill Patients

Critically ill patients undergo significant pathophysiological changes that affect antibiotic pharmacokinetics. Piperacillin/tazobactam administered by continuous infusion (CI) improves pharmacokinetic/pharmacodynamic (PK/PD) target attainment. This study aimed to characterize piperacillin PK after...

Descripción completa

Detalles Bibliográficos
Autores principales:	Martínez-Casanova, Javier, Esteve-Pitarch, Erika, Colom-Codina, Helena, Gumucio-Sanguino, Víctor Daniel, Cobo-Sacristán, Sara, Shaw, Evelyn, Maisterra-Santos, Kristel, Sabater-Riera, Joan, Pérez-Fernandez, Xosé L., Rigo-Bonnin, Raül, Tubau-Quintano, Fe, Carratalà, Jordi, Padullés-Zamora, Ariadna
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10044067/ https://www.ncbi.nlm.nih.gov/pubmed/36978398 http://dx.doi.org/10.3390/antibiotics12030531

Ejemplares similares

Voriconazole Pharmacokinetics in Critically Ill Patients and Extracorporeal Membrane Oxygenation Support: A Retrospective Comparative Case-Control Study
por: Ronda, Mar, et al.
Publicado: (2023)

Antimicrobial use and aetiology of bloodstream infections in critically ill patients during early stages of SARS-CoV-2 pandemic
por: Torrecillas, Miriam, et al.
Publicado: (2022)

Individual outcome prediction models for patients with COVID-19 based on their first day of admission to the intensive care unit
por: Rigo-Bonnin, Raúl, et al.
Publicado: (2021)

Continuous infusion of piperacillin‐tazobactam significantly improves target attainment in children with cancer and fever
por: Maarbjerg, Sabine F., et al.
Publicado: (2021)

Infectious diseases experts as part of the antibiotic stewardship team in primary care: protocol for a cluster-randomised blinded study (IDASP)
por: Ronda, Mar, et al.
Publicado: (2021)

Population Pharmacokinetic Modeling and Pharmacodynamic Target Attainment Simulation of Piperacillin/Tazobactam for Dosing Optimization in Late Elderly Patients with Pneumonia
por: Ishihara, Noriyuki, et al.
Publicado: (2020)

Similar Piperacillin/Tazobactam Target Attainment in Obese versus Nonobese Patients despite Differences in Interstitial Tissue Fluid Pharmacokinetics
por: Busse, David, et al.
Publicado: (2021)

Management of Tizanidine Withdrawal Syndrome: A Case Report
por: Suárez-Lledó, A, et al.
Publicado: (2018)

Pharmacodynamic Target Attainment for Meropenem and Piperacillin/Tazobactam Using a PK/PD-based Dosing Calculator in Critically Ill Patients
por: Heil, Emily, et al.
Publicado: (2017)

Timing of continuous renal replacement therapies in acute kidney injury patients after cardiac surgery
por: Cardenas Campos, P, et al.
Publicado: (2015)

Efficacy of extended infusion of β-lactam antibiotics for the treatment of febrile neutropenia in haematologic patients: protocol for a randomised, multicentre, open-label, superiority clinical trial (BEATLE)
por: Laporte-Amargos, J., et al.
Publicado: (2020)

Piperacillin/Tazobactam (ZOSYN)
por: Culver, Stephanie M., et al.
Publicado: (1996)

Pharmacokinetic/Pharmacodynamic Target Attainment of Continuous Infusion Piperacillin–Tazobactam or Meropenem and Microbiological Outcome among Urologic Patients with Documented Gram-Negative Infections
por: Berrino, Pasquale Maria, et al.
Publicado: (2023)

The Etiology, Incidence, and Impact of Preservation Fluid Contamination during Liver Transplantation
por: Oriol, Isabel, et al.
Publicado: (2016)

Mechanisms of Piperacillin/Tazobactam Nephrotoxicity: Piperacillin/Tazobactam-Induced Direct Tubular Damage in Mice
por: Yang, Jihyun, et al.
Publicado: (2023)

Molecular Epidemiology of Nontypeable Haemophilus influenzae Causing Community-Acquired Pneumonia in Adults
por: Puig, Carmen, et al.
Publicado: (2013)

Risk Factors and Outcomes of Acute Graft Pyelonephritis with Bacteremia Due to Multidrug-Resistant Gram-Negative Bacilli among Kidney Transplant Recipients
por: Sabé, Núria, et al.
Publicado: (2022)

Piperacillin/tazobactam Induced Myelosuppression
por: Lee, Kirsty Wai Chung, et al.
Publicado: (2009)

Pre-existing Autoantibodies Neutralizing High Concentrations of Type I Interferons in Almost 10% of COVID-19 Patients Admitted to Intensive Care in Barcelona
por: Solanich, Xavier, et al.
Publicado: (2021)

Meropenem and piperacillin/tazobactam prescribing in critically ill patients: does augmented renal clearance affect pharmacokinetic/pharmacodynamic target attainment when extended infusions are used?
por: Carlier, Mieke, et al.
Publicado: (2013)

Antibiotic prescription during the COVID-19 pandemic: A biphasic pattern
por: Abelenda-Alonso, Gabriela, et al.
Publicado: (2020)

COVID-19 ARDS: getting ventilation right
por: Pérez-Fernández, Xosé L, et al.
Publicado: (2022)

A Case of Piperacillin-induced Occupational Anaphylaxis: Detection of Serum IgE to Piperacillin-HSA Conjugate
por: Kim, Jeong-Eun, et al.
Publicado: (2011)

Severe Acute Kidney Injury in Patients with COVID-19 and Acute Respiratory Distress Syndrome
por: Chaibi, Khalil, et al.
Publicado: (2020)

Pathogen-based target attainment of optimized continuous infusion dosing regimens of piperacillin-tazobactam and meropenem in surgical ICU patients: a prospective single center observational study
por: De Corte, Thomas, et al.
Publicado: (2023)

Myoclonic Jerks Secondary to Piperacillin and Nafcillin
por: Meyer, Michael A.
Publicado: (2014)

DRESS syndrome induced by piperacillin-tazobactam
por: Sanchez-Gonzalez, Maria-Jose, et al.
Publicado: (2014)

Early Target Attainment With Continuous Infusion Meropenem and Piperacillin/Tazobactam and Utilization of Therapeutic Drug Monitoring in Critically Ill Patients: A Retrospective Cohort Study From 2017 to 2020
por: Dräger, Sarah, et al.
Publicado: (2023)

Days spent on non-invasive ventilation support: can it determine when to initiate VV- ECMO? Observational study in a cohort of Covid-19 patients
por: Fuset-Cabanes, María P., et al.
Publicado: (2023)

Enterobacter endophthalmitis: Treatment with intravitreal tazobactam- piperacillin
por: Singh, Trehan Hemant, et al.
Publicado: (2007)

Piperacillin-tazobactam-induced hypokalemia and metabolic alkalosis
por: Zaki, Syed Ahmed, et al.
Publicado: (2011)

Inadvertent Injection of Piperacillin - Tazobactum into Epidural Space
por: Agarwal, Apurva, et al.
Publicado: (2010)

Piperacillin–tazobactam as alternative to carbapenems for ICU patients
por: Pilmis, Benoit, et al.
Publicado: (2017)

Piperacillin/tazobactam: Eosinophilic-pneumonia: case report
Publicado: (2021)

Piperacillin: Immune haemolytic anaemia: case report
Publicado: (2022)

1555. Risk of Developing Acute Kidney Injury in Patients Receiving Piperacillin–Tazobactam and Vancomycin Compared with Those on Piperacillin–Tazobactam and Telavancin
por: Reilly, Joseph, et al.
Publicado: (2019)

Evaluation of Piperacillin/Sulbactam, Piperacillin/Tazobactam and Cefoperazone/Sulbactam Dosages in Gram-Negative Bacterial Bloodstream Infections by Monte Carlo Simulation
por: Wang, Xueting, et al.
Publicado: (2023)

Piperacillin/tazobactem induced epistaxis- A case report
por: Tomar, Gaurav Singh, et al.
Publicado: (2012)

Characterization of the TCR V repertoire of piperacillin-specific T-cells
por: Al-Attar, Zaid, et al.
Publicado: (2014)

Pulmonary Penetration of Piperacillin and Tazobactam in Critically Ill Patients
por: Felton, T W, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_oisn35mj4hit2tn9dl5h0lglp6